byiShook Opinion
Mar 31, 2025 - 13:10
AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results could buoy AstraZeneca stock. The post Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol? appeared first on Investor's Business Daily.
AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results could buoy AstraZeneca stock.
The post Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol? appeared first on Investor's Business Daily.